Prostate Cancer Screening & Genetic Testing: The NCCN Perspective

Posted by J. Kellogg Parsons, MD, MHS, FACS | Jan 2020

J. Kellogg Parsons, MD, MHS, presented “Prostate Cancer Screening & Genetic Testing: The NCCN Perspective” for the Grand Rounds in Urology audience in January, 2020.

How to cite: Parsons, J. Kellogg. “Prostate Cancer Screening & Genetic Testing: The NCCN Perspective” January, 2020. Accessed Apr 2024. https://grandroundsinurology.com/prostate-cancer-screening-genetic-testing-the-nccn-perspective/

Prostate Cancer Screening & Genetic Testing: The NCCN Perspective – Summary:

J. Kellogg Parsons, MD, MHS, discusses the rationale behind the National Comprehensive Cancer Network (NCCN) guidelines on prostate cancer screening and how they fit in with currently available genetic testing. He describes the multi-disciplinary makeup of the NCCN, details considerations that led to their recommendations on when men should be screened and in which circumstances, and outlines opportunities to improve the guidelines through standardization, coordination with other organizations, and improved treatment algorithms.

This educational activity is based on a series of lectures on genetic testing for prostate cancer from the 2019 Philadelphia Prostate Cancer Consensus Conference. Further activities from this conference include:

Germline Predisposition for Prostate Cancer Among African American and Other Minorities: What Do We Know?
Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness
A Urologist’s Perspective on Germline Testing
Integration of Germline Testing in Prostate Cancer Screening
Current NCCN Recommendations for Prostate Cancer Genetic Testing
The Expanding World of Germline Testing for Prostate Cancer: Genetic Counseling Perspective
The Expanding World of Germline Testing for Prostate Cancer: A Clinical Trials Perspective
Current Prostate Cancer Genetic Testing Capabilities and Considerations

About The Author

J. Kellogg Parsons, MD, MHS, FACS

J. Kellogg Parsons, MD, MHS, is a board-certified urologist who specializes in diagnosing and treating prostate cancer. He is a Professor of Urology at the University of California, San Diego. He also directs clinical trials for the Department of Urology at UC San Diego Health’s Moores Cancer Center. Dr. Parsons is an expert in nerve-sparing robotic surgery, cryosurgery, and MRI of the prostate, and is internationally recognized for his work in prostate disease. He has repeatedly been named a top doctor in San Diego Magazine’s “Physicians of Exceptional Excellence” annual survey, performed in collaboration with the San Diego County Medical Society. He has also been recognized as one of America’s Best Doctors®. He has published over 130 scientific research articles, edited four medical textbooks, received multiple research grants, and serves as an editor on three scientific journals. He has won numerous awards for his scientific research, lectures extensively across the US and in Europe and Asia, and serves on several national committees. Dr. Parsons completed his residency and fellowship training at John Hopkins School of Medicine in Baltimore. He earned his medical degree from the University of Pennsylvania School of Medicine in Philadelphia and holds a Master of Health Science in Clinical Investigation degree from Johns Hopkins Bloomberg School of Public Health. Dr. Parsons is also the award-winning author of the novels Doing Harm and Under the Knife. He is currently at work on his third book.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat